Here's Why Chinook Therapeutics (KDNY) is a Great Momentum Stock to BuyZacks Investment Research • 07/13/22
Here's Why "Trend" Investors Would Love Betting on Chinook (KDNY)Zacks Investment Research • 07/13/22
Chinook Therapeutics to Present at the William Blair Biotech Focus Conference 2022GlobeNewsWire • 07/05/22
Chinook Therapeutics Receives Orphan Drug Designation from European Commission for BION-1301 for Treatment of Primary IgA Nephropathy (IgAN)GlobeNewsWire • 07/05/22
Wall Street Analysts See a 94% Upside in Chinook (KDNY): Can the Stock Really Move This High?Zacks Investment Research • 06/24/22
Does Chinook (KDNY) Have the Potential to Rally 110% as Wall Street Analysts Expect?Zacks Investment Research • 06/08/22
Wall Street Analysts Believe Chinook (KDNY) Could Rally 110%: Here's is How to TradeZacks Investment Research • 05/23/22
Chinook Therapeutics Presents Data from Atrasentan Phase 2 AFFINITY IgA Nephropathy (IgAN) Patient Cohort and Evotec Collaboration at the 59th European Renal Association (ERA) Congress 2022GlobeNewsWire • 05/20/22
Chinook's Kidney Disease Candidate Continues To Show Rapid, Sustained Reductions In BiomarkersBenzinga • 05/19/22
Chinook Therapeutics Presents Updated Data from BION-1301 Phase 1/2 Trial in Patients with IgA Nephropathy (IgAN) and from Atrasentan Preclinical Mechanism of Action Studies at the 59th European Renal Association (ERA) Congress 2022GlobeNewsWire • 05/19/22
Chinook Therapeutics Provides Business Update and Reports First Quarter 2022 Financial ResultsGlobeNewsWire • 05/12/22
Chinook Therapeutics Announces Upcoming Data Presentations and Investor Conference Call at the 59th European Renal Association (ERA) CongressGlobeNewsWire • 05/02/22
Chinook Therapeutics to Present at the 2022 Bloom Burton & Co. Healthcare Investor ConferenceGlobeNewsWire • 04/25/22
Chinook Therapeutics Announces Initiation of Phase 1 Healthy Volunteer Trial of CHK-336, a First-in-Class LDHA Inhibitor to Treat HyperoxaluriasGlobeNewsWire • 04/12/22
Chinook Therapeutics to Present at the 21st Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/05/22
Chinook Therapeutics, IgA Nephropathy Foundation and Komodo Health Collaborate to Provide Nephrologists with Support and Information to Help Reduce Barriers to Diagnosis and CareGlobeNewsWire • 04/05/22
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of DirectorsGlobeNewsWire • 03/21/22